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INTRODUCTION
In liver transplantation for liver cancer, the pres-
ence of micro cancer cells in the recipient’s blood is
a problem leading to recurrence in the transplanted
liver. For colonization of micro liver cancer cells in
the liver graft, as for metastasis and liver invasion by
cancers of digestive organs, it is essential that floating
cancer cells are disseminated in blood, then adhere to
vascular endothelial cells in the liver graft and pass
through the cell membrane forming thick basement
membrane similar to vascular endothelial cells, unlike
the normal liver. In this study, using a cell membrane
consisting of components similar to those of liver
grafts with thick basement membrane in ischemia
reperfusion, the effects of immunosuppressors FK
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506 and cyclosporine A (CsA) on permeation of cancer
cells through the basement membrane of liver grafts
and invasion/metastasis were investigated. Focusing
on adhesion of cancer cells, the effects of FK506 and
CsA on an adhesion molecule, ICAM-1, was also in-
vestigated.
MATERIALS AND METHODS
Cell lines and culture
Two human HCC cell lines with different clinical
characteristics, such as poorly differentiated type cell
line (HLE) and the well-differentiated type cell line
(HuH-7), were obtained from Japan health sciences
foundation and used in this study. Both cell lines were
maintained in RPMI 1640medium(Gibco,Grand Island,
NY, USA) containing 10% fetal calf serum (FCS) at
37℃ under 5%CO2. The cells were seeded into 75 cm2
flasks (Sumitomo, Akita, Japan), grown to confluence.
The cells in the early stationary phase were washed
3 times with phosphate-buffered saline (PBS)(Nissui
Pharmaceutical Co Ltd, Tokyo, Japan), and the cells
in the conditionedmediumwere used for experiments.
Chemicals
FK506 (Fujisawa Pharmaceutical Company, Osaka,
Japan) and CsA (Sandoz, Basel, Suitzerland) were
dissolved in ethanol as stock solutions and were di-
luted at various concentrations with culture media
before use. It was confirmed that the final concentra-




Both HLE and HuH-7 cells were cultured asmono-
layers under the conditions described above to reach
confluence. After washing 3 times with PBS, the cells
in condition medium containing 10% FCS were seeded
into 24-well round bottom microtest plate (FALCON
3047, Becton Dickinson Microbiology Systems, CA,
USA) and then cultured for 6 days. The cells at 2×104
per well in a 24-well plate were treated with FK506
and CsA at various concentrations of 1-1000ng/mL
for additional 6 days. Viable cells were counted with
a hemocytometer after trypan blue staining.
Evaluation of cytotoxicity
Both HLE and HuH-7 cells were cultured in 24-well
cell plate (2×104 cells/well) with or without FK506
or CsA at concentrations described above. At the late
exponential phase of cell growth on day 5 for HLE and
on day 4 for HuH-7, FK506 and CsA were removed by
washing and then cells were further cultured in RPMI
1640 containing 10% FCS. Viable cells were counted
using trypan blue staining and presented as % control
value, regarding the cell numbers in the control group
as 100%.
Invasion assay
TheMatrigel invasion chamber (Bection Dickinson
Labware, Bedford, MA, USA) consists of 8.0 micron
pore size (1×105pores/cm2) polyethylene terephthalate
(PET) membrane chamber coatedwith a consistently
uniform layer of Matrigel basement membranematrix
(100µg/cm2). TheMatrigel basementmembranematrix
contains laminin, collagen typeⅣ, heparan sulfate pro-
teoglycan and entactin, being similar to the matrix be-
tween the portal vein and the hepatocytes in the liver.
The human hepatic cancer cell lines were detached
from the culture flasks by the conditionedmedia. The
cells were then washed 3 times with culture media,
suspended at 2×104 cells in 100µL in the upper com-
portment of the Transwell insert. FK506 andCsAwere
added to culture media at concentrations of 1,10, and
100 ng/mL and 1,10,100,1000 ng/mL, respectively,
and culture media without addition of these reagents
were used as a control experiment. FK506 concen-
trations in media of 24 well chamber or of the upper
compartment in the invasion assays were measured
by Enzyme immunoassay and CsA concentrations
by Radio immunoassay. To the lower compartment,
600 µL of the media containing 20 µg/mL of fibronec-
tion were added. The chambers were incubated at
37℃ in 5% CO2 for 6 days. The numbers of cancer cells
in the upper compartment and those that invaded
into the lower compartment on days one through six
of culture were calculated by trypan blue exclusion
test. Furthermore, cancer cells on the upper surface
of the PET membrane were fixed in methanol and
stained with hematoxylin-eosion using Diff-Quick
Stain kit (Baxter), and the number of these cells was
counted under a lightmicroscope (×200). Percent ratio
of the invaded cells in the lower compartment was
defined as follows :
% invasion = [number of cancer cells that invaded into
the lower compartment/the number of cancer cells
in the upper compartment ＋ number of cancer cells
that invaded into the lower compartment]×100
Analysis of the levels of soluble ICAM-1(sICAM-1)
in human cancer cells
The levels of sICAM-1 in culture media produced
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by HLE and HuH-7 in the upper compartments of the
invasion chambers in the presence or the absence of
FK506 and CsA were measured by using TaKaRa EIA
kits (TaKaRa BIOMEDICALS, Outsu, Shiga, Japan).
Three experiments were performed in triplicate in
each time point.
Statistical Analysis
All values are expressed as means±SD. Statistical
significance was evaluated using analysis of variance
followed by the Student’s t-test. Values of p<0.05 were
considered to be statistically significant.
RESULTS
Inhibitory effects of FK506 and CsA on the growth
of HLE
As shown in Figure 1A, FK506 at a concentration
of 1ng/mL significantly inhibited the growth of poorly
differentiated cell line of HLE during the incubation for
1-5 days (p<0.05). However, FK506 at a concentration
of 10ng/mL revealed less inhibitory effect than FK
506 at1ng/mL did and no significant growth inhibition
was observed on days 1 and 2. FK506 at a concentra-
tion of 100ng/mL showed cytotoxicity. CsA at con-
centrations of 1-1000ng/mL inhibited the growth of
HLE in a dose-dependent manner, as shown in Figure
1 B (p<0.01), but CsA at concentrations over 100ng/
mL revealed cytotoxicity as shown in the following
results.
Inhibitory effects of FK506 and CsA on the growth
of HuH-7
FK506 also significantly inhibited the growth of the
well differentiated cell line HuH-7 at concentrations
over 1ng/mL (p<0.01), but no significant difference in
the inhibitory effects were observed at the concen-
trations of FK506 between 1 and 10 ng/mL (Figure
1 C). CsA at concentrations over 1ng/mL inhibited
the growth ofHuH-7. CsA at 10 ng/mL revealed further
inhibitory effect on days 1 and 2 (p<0.01), but no sig-
nificant difference in the inhibitory effect between 1
and 10 ng/mL was observed after incubation for 3 days
(Figure 1 D). CsA at concentrations over 100 ng/mL
revealed cytotoxic effects on HuH-7 as shown in the
following results.
Figure. 1. Inhibition of the growth of human liver cancer cells, HLE and HuH-7, by FK506 and CsA.
HLE (A and B) and HuH-7 (C and D) at 2×104 cells/well were incubated with various concentrations of
FK506 (A and C) and CsA (B and D) for 6 days. **p<0.01 ; *p<0.05
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Evaluation of the FK506 and CsA cytotoxicity on
HLE and HuH-7
FK506 and CsA were removed by washing after
incubation for 5 days for HLE and for 4 days for HuH-
7, and these cell lines were further cultured without
these immunosuppressors for an evaluation of cell
viability. The cells treated with FK506 at a concen-
tration of 100 ng/mL and those treated with CsA at
concentrations over 100ng/mL did not grow after re-
moval of these immunosuppressors as shown in Figure
2A and 2B, respectively indicating that these reagents
at concentrations over 100 ng/mL show cytotoxicity.
Inhibitory effects of FK506 and CsA on the invasion
of HLE and HuH-7
FK506 at a concentration of 1ng/mL significantly
inhibited the invasion of a poorly differentiated HLE
but less inhibitory effect was observed at a concen-
tration of 10 ng/mL (Figure 3A and 3B) (p<0.05). FK
506, however, showed no significant inhibitory effect
on the well differentiated HuH-7 (Figure 3C). In con-
trast, CsA at concentrations of 1 and 10 ng/mL showed
almost no inhibitory effect on the invasion of both HLE
and HuH-7.
Measurement of sICAM-1levels in the media of HLE
and HuH-7
The levels of sICAM-1 production increased along
with an increase in cell number until the peak of cel-
lular proliferation of HLE and HuH-7 around on day
3 and then decreased. Big difference in the levels of
of sICAM-1 production was observed between HLE
and HuH-7 : the maximal level of sICAM-1 production
in the poorly differentiated HLE on day 3 was 773.3±
Figure. 2. The cytotoxic effect of FK506 and CsA on HLE and HuH-7.
FK506 (A) and CsA (B) at various concentrations were added to HLE and HuH-7 cells (2×104cells/ well) for several days
and then removed by washing. Day 0 is defined as day on which FK506 and CsA were removed. Then these cells were
further cultured in the conditioned media. The results represent the percentage of response compared with the non-
treated control.
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20.8 ng/mL and that of sICAM-1 production in the
well differentiated HuH-7 on day 3 was 50.0±0.5 ng/
mL (Figure 4).
Effects of FK506 and CsA on ICAM-1production in HLE
FK506 at concentrations of 1 and 10 ng/mL inhib-
ited the ICAM-1 production in a dose-dependent man-
ner after incubation for 2 days on days 3 and 4 (p<0.01)
but the inhibitory effect was not evident on the initial
days 1 and 2 and the last days on days 5 and 6 (Figure
5A). CsA at concentrations of 1 ng/mL and 10 ng/
mL significantly inhibited the ICAM-1 production dur-
ing the incubation time (p<0.01) except the last experi-
mental days on days 5 and 6.
DISCUSSIOIN
Permeation of micro cancer cells through the base-
ment membrane in the process of cancer recurrence in
liver grafts is a principal problem in liver transplan-
tation. Unlike normal liver, the basement membranes
in hepatic cirrhosis, liver cancer, inflammatory reac-
tions during grafting, and ischemic disorder, become
thick by producing ECM(1-3). Klintmalm et al . re-
ported that the prognosis of liver transplantation for
the 5 cm or lessHCC is better in poorly-differentiated
carcinoma than in well-differentiated carcinoma,
indicating that the histological type of liver cancer
at the time of liver transplantation is important (4).
To clarify the effects of immunosuppressors during the
perioperative period of transplantation on cancer re-
currence in liver grafts, we used a well-differentiated
HCC cell line producing AFP, HuH-7, and a poorly-
differentiated HLE cell lines of HCC (5, 6) in the inva-
sion assay by using the invasion chamber, since the
structure of the thick basement membranes is similar
to that of the invasion chamber used in this study (7-9).
In this model, liver cancer cells move from the upper
to lower chambers through the cell membrane, the
conditions being similar to those of cancer cells pre-
sent in the recipient’s blood which invade the liver
graft via the portal vein or hepatic vein system.
Considering the results of the cytotoxicity of FK
506 and CsA for HLE or HuH-7, FK506 and CsA at
concentrations of 1-10 ng/mLwere used in the invasion
Figure. 3. Inhibition of the invasion of HLE and HuH-7 by FK506 and CsA.
The Matrigel invasion chamber was used to analyze the effect of FK506 and CsA for the invasiveness of HLE cells (A ;
FK506, B ; CsA) and HuH-7 cells (C ; FK506, D ; CsA) The % invasion was determined by the methods described under
“Materials and Methods”. **p<0.01 ; *p<0.05
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assay. These concentrations are close to the blood
through values of FK506 and CsA clinically used in
liver transplantation. FK506 at 1 and 10 ng/mL inhib-
ited the invasion activity of a poorly differentiated
HLE after treatment for 2-5 days in culture, but there
was no significant difference in the inhibitory effects
between these two concentrations. FK506 at 1 and
10 ng/mL, however, did not inhibit the invasion of a
well differentiated HuH-7. In contrast, CsA did not
show any inhibitory effects on the invasion activity of
both HLE and HuH-7 at concentrations of 1 and 10
ng/mL.
The effects of FK506 and CsA on the production
of sICAM-1were investigated. ICAM-1 is involved in
adhesion of cancer cells to vascular endothelial cells,
which is necessary as the first step, entrance into the
metastasizing tissue (grafted liver in liver transplanta-
tion) of infiltrative metastasis by cancer cells dissemi-
nated in the peripheral blood (10,11). FK506 at con-
centrations of 1 and 10 ng/mL inhibited the sICAM-1
production in the upper chamber of HLE at the prolif-
eration stage, suggesting that FK506 inhibits adhe-
sion of cancer cells to ECMof the grafted liver by inhib-
iting ICAM-1 production. Since FK506 at 1 ng/mL
inhibited sICAM-1 more strongly than FK506 at 10
ng/mL, a low concentration of FK506 may be advan-
tageous for prevention of cancer recurrence in the trans-
planted liver when used in liver transplantation for
liver cancer in actual clinical practice. In addition, it
has been reported that FK506 inhibited expression
of ICAM-1 around the portal vein and hepatic veins
in a rat liver ischemia-perfusion experiment (12). Fur-
thermore, possibility of intrahepatic metastasis via the
portal vein and hepatic veins (13) and increased ICAM-1
Figure. 4. Time course of sICAM-1 production in HLE and HuH-7.
The sICAM-1 production by HLE cells (A) and HuH-7 cells (B) were measured as described under“Materials and Methods”.
Figure. 5. Inhibitory effects of FK506 and CsA on the production of sICAM-1 in HLE.
(A) Inhibition of sICAM-1 production by FK506 at 1 and 10 ng/mL ; (B) Inhibition of sICAM-1 production by CsA at 1 and
10 ng/mL. **p<0.01
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production with the progression of intrahepatic me-
tastasis have been reported (10,11). Considering of
these findings, FK506 was suggested to inhibit recur-
rence in transplanted liver via inhibition of ICAM-1
production. Although CsA also inhibited the produc-
tion of sICAM-1in HLE, it did not inhibit or transiently
and a little inhibited the invasion. Further studies
on the mechanisms of the inhibitory effect of FK506
and CsA on the invasion of HLE are now under in-
vestigation.
Generally, immunosuppressors promote growth
of tumors according to previous reported (14), but
not within a specified concentration range in a report
(15). This study showed that FK506 has an inhibitory
effects on the production of ICAM-1, and on the invasion
of liver cancer cells at 1 and 10 ng/mL. These results
suggest that FK506 treatment is clinically useful for
the inhibition of micro liver cancer cell invasion in
liver transplantation.
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